Breakthrough trial aims to extend lives in advanced stomach cancer
NCT ID NCT07118527
Summary
This study is testing whether a new drug combination works better than current standard treatment for advanced stomach cancer that cannot be removed by surgery. The trial will involve 600 patients who haven't received previous treatment for their advanced cancer. Researchers will compare how long patients live without their cancer getting worse and how long they survive overall between the two treatment approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC UNTREATED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110001, China
Contact
-
Zhongshan Hospital，Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact
Conditions
Explore the condition pages connected to this study.